Orthofix International reported $137.23M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
AngioDynamics USD 6.3M 6.3M Feb/2025
AtriCure USD 77.25M 15.39M Jun/2025
Dexcom USD 2.45B 132.5M Sep/2025
EDAP TMS EUR 8.96M 4.96M Jun/2025
Globus Medical USD 121.1M 120.63M Jun/2025
Hologic USD 2.63B 104.3M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
J&J USD 45.8B 4.97B Sep/2025
Medtronic USD 28.61B 93M Jun/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Smith & Nephew USD 3.32B 334M Dec/2024
STAAR Surgical USD 40.52M 40.14M Jun/2025
Stryker USD 14.86B 1.74B Dec/2025
Surmodics USD 29.55M 111K Sep/2024
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teleflex USD 2B 180.08M Jun/2025
Veracyte USD 50.65M 145K Jun/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025